Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic
  • Search Hotels in Los Altos

  • ROOMS:

Safe & Green Holdings Corp. Announces the Appointment of Jill Anderson to the Company’s Board of Directors

Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures for residential, commercial, and point-of-care medicine, today announced the appointment of Jill Anderson to the Company’s Board of Directors.

This press release features multimedia. View the full release here:

Jill Anderson (Photo: Business Wire)

Jill Anderson (Photo: Business Wire)

Ms. Anderson currently serves as Chief Legal Officer of miR Scientific, LLC, a precision healthcare company committed to transforming cancer management globally by developing non-invasive tests for the detection and risk classification of cancers. Ms. Anderson was previously a partner at the law firm of Moses & Singer LLP in New York City, where she advised sophisticated healthcare clients, including clinical laboratories, biotechnology and healthcare technology companies, non-profit research foundations and provider organizations. Before that, Ms. Anderson held legal roles in internationally recognized healthcare organizations, Dana-Farber Cancer Institute and Mass General Brigham (formerly Partners Healthcare System). Ms. Anderson brings invaluable health law and regulatory expertise with a broad skill set in everything from manufacturing and infrastructure to intellectual property to data privacy to negotiating strategic partnerships and revenue-share models. Ms. Anderson also serves on the Board of Directors of Fight Cancer Global, a nonprofit organization dedicated to creating patient-centric solutions which unite all constituents to end the isolation for cancer patients globally. Ms. Anderson earned her J.D. at Widener University School of Law and holds a Bachelor of Science degree in Pre-Medicine from Rutgers University.

Paul Galvin, Chairman and CEO commented, “I am honored to welcome Jill as our newest independent board member. She is a highly accomplished executive and legal expert, with significant experience in the healthcare field. We look forward to leveraging her extensive experience and broad industry relationships as we seek to continue the growth of SG Echo, complete the spin-out of SG DevCo, and, in particular, accelerate the rollout of our medical subsidiary.”

About Safe & Green Holdings Corp.

Safe & Green Holdings Corp., a leading modular solutions company, operates under core capabilities which include the development, design, and fabrication of modular structures, meeting the demand for safe and green solutions across various industries. The firm supports third party and in-house developers, architects, builders and owners in achieving faster execution, greener construction, and buildings of higher value. The Company’s subsidiary, Safe and Green Development Corporation, is a leading real estate development company. Formed in 2021, it focuses on the development of sites using purpose built, prefabricated modules built from both wood and steel, sourced from one of Safe & Green Holdings’ factories and operated by the SG Echo subsidiary. For more information, visit and follow us at @SGHcorp on Twitter.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding leveraging the new board member’s experience and industry relationships; continuing the growth of SG Echo; completing the spin-out of SG DevCo, as well as accelerating the rollout of the Company’s medical subsidiary. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include but are not limited to the factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.